Smartleaf Asset Management
IRWD icon

Smartleaf Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Smartleaf Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4 Hold
1
– – ﹤0.01% 3613
2026
Q2 		$4 Hold
1
– – ﹤0.01% 3453
2026
Q1 		$3 Hold
1
– – ﹤0.01% 3499
2025
Q4 		$3 Buy
+1
New +$3 ﹤0.01% 3483
2025
Q2 		– Sell
-2,652
Closed -$3.74K – 2855
2025
Q1 		$3.74K Buy
2,652
+1,473
+125% +$3.51K ﹤0.01% 2284
2024
Q4 		$5.16K Buy
1,179
+150
+15% +$609 ﹤0.01% 2236
2024
Q3 		$4.14K Buy
1,029
+706
+219% +$3.8K ﹤0.01% 2206
2024
Q2 		$2K Buy
323
+282
+688% +$2K ﹤0.01% 2224
2024
Q1 		$353 Buy
+41
New +$498 ﹤0.01% 1793

Other funds holding IRWD

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Ritholtz Wealth Management
Ritholtz Wealth Management New York $6.96B AUM 24% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Smartleaf Asset Management's IRWD Position: Q3 2026 in Review

Smartleaf Asset Management held its Ironwood Pharmaceuticals (IRWD) position steady in Q3 2026 at 1 share worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #3613.

Smartleaf Asset Management first reported a position in IRWD in Q1 2024 and has held it in 9 quarters since. The position peaked at $5.16K in Q4 2024. 112 funds tracked by Wall St. Rank hold IRWD as of Q3 2026.

  • Smartleaf Asset Management held 1 share of Ironwood Pharmaceuticals worth $4 as of Q3 2026.
  • Smartleaf Asset Management left its Ironwood Pharmaceuticals share count unchanged in Q3 2026.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #3613 holding.
  • Smartleaf Asset Management first reported a position in Ironwood Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
  • Smartleaf Asset Management's Ironwood Pharmaceuticals position peaked at $5.16K in Q4 2024.
  • 112 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.